CSIMarket
 


Opiant Pharmaceuticals Inc   (OPNT)
Other Ticker:  
 
 

Opiant Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2022 to the third quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Opiant Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 4.1, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Opiant Pharmaceuticals Inc 's Average receivable collection period in the Sep 30 2022 quarter, has increased to 89 days, from 88 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 325 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2416, from overall ranking in the second quarter 2022 at 2879.

What is Receivable Turnover Ratio?
What is Opiant Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




OPNT Receivables Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Receivable Change -99.73 % -59.15 % -20.6 % 49.56 % 79.09 %
Y / Y Revenue Change -98.94 % -65.41 % -30.01 % 39.06 % 79.43 %
Receivable Turnover Ratio (TTM) 4.1 4.14 4.27 4.34 4.43
OPNT's Total Ranking # 2416 # 2879 # 1104 # 2406 # 3177
Average receivable collection period 89 88 85 84 82
Seq. Receivable Change -98.97 % -10.8 % -66.58 % -13.6 % 58.62 %
Seq. Revenue Change -95.54 % -12.88 % -67.61 % -15.54 % 45.12 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 84
Healthcare Sector # 326
Overall Market # 2416

Receivable Turnover Ratio Statistics
High Average Low
1.72 0.81 0.4
(Oct 31 2017)   (Sep 30 2022)






Financial Statements
Opiant Pharmaceuticals Inc 's Accounts Receivable $ 0 Millions Visit OPNT's Balance sheet
Opiant Pharmaceuticals Inc 's Sales TTM $ 22 Millions Visit OPNT's Income Statement
Where are OPNT's Sales coming from? Visit OPNT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OPNT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for OPNT's Competitors
Receivables Turnover Ratio for OPNT's Suppliers
Accounts Receivables Turnover Ratio for OPNT's Customers

You may also want to know
OPNT's Growth Rates OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Dividend Comparisons
OPNT's Profitability Ratios OPNT's Roi OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Valuation Ratios OPNT's Roe OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Receivable at quarter ending Sep 30 2022
Logicbio Therapeutics Inc   1,434.53 $ 10.759  Millions$ 0.008  Millions
P3 Health Partners Inc   1,376.98 $ 1,282.322  Millions$ 0.931  Millions
Xoma Corporation  646.95 $ 41.243  Millions$ 0.064  Millions
Warby Parker Inc   328.02 $ 314.246  Millions$ 0.958  Millions
Arrowhead Pharmaceuticals Inc   312.23 $ 243.231  Millions$ 0.779  Millions
Clearday Inc   308.77 $ 22.285  Millions$ 0.072  Millions
Iqvia Holdings Inc   298.06 $ 14,307.000  Millions$ 48.000  Millions
Sigilon Therapeutics Inc   294.37 $ 12.290  Millions$ 0.042  Millions
Chimerix Inc   282.53 $ 33.056  Millions$ 0.117  Millions
Denali Therapeutics Inc   279.71 $ 110.694  Millions$ 0.396  Millions
Nexalin Technology Inc   210.71 $ 0.545  Millions$ 0.003  Millions
China Pharma Holdings Inc   191.12 $ 8.072  Millions$ 0.042  Millions
Sunshine Biopharma Inc   186.61 $ 0.419  Millions$ 0.002  Millions
4d Molecular Therapeutics Inc   167.91 $ 1.973  Millions$ 0.012  Millions
Marpai Inc   160.52 $ 11.914  Millions$ 0.074  Millions
Arcus Biosciences Inc   149.36 $ 432.844  Millions$ 2.898  Millions
Lipocine Inc   136.01 $ 16.611  Millions$ 0.122  Millions
Biosig Technologies Inc   127.20 $ 0.159  Millions$ 0.001  Millions
Oragenics Inc   125.09 $ 0.219  Millions$ 0.002  Millions
Atara Biotherapeutics Inc   111.65 $ 70.900  Millions$ 0.635  Millions

Date modified: 2022-11-16T06:30:24+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com